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concentrated urine samples and underlying disease of
patients in our study.1 Even under universal immunization
with conjugate pneumococcal vaccine, Streptococcus
pneumoniae remains the leading pathogen in childhood
community acquired pneumonia.2,3 One of the challenges
facing clinicians is to explore the early detection of pneu-
mococcal disease by disease severity in hospitalized
patients. Current urinary antigen test scores were obtained
using original unconcentrated urine samples from patients
at admission in our study. The correlation between urine
specific gravity and the urinary antigen test scores was
studied. The urinary antigen test reaction may have been
slightly enhanced by the higher urine specific gravity.
However, the time to positive reaction and the intensity of
reaction band were not influenced by the urinary gravity.
The findings were also in agreement with a report by Tateda
et al,4 who suggested that the fold difference between
severe and non-severe groups could not be achieved by
urinary concentration under normal physiological status.* Corresponding author. Department of Pediatrics, National
Cheng Kung University Hospital, College of Medicine, National
Cheng Kung University, Tainan, Taiwan.
E-mail address: liucc@mail.ncku.edu.tw (C.-C. Liu).
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http://dx.doi.org/10.1016/j.jfma.2012.10.001The underlying illness of patients did not influence the
result of the urinary antigen test score and its application
in disease severity assessment. First, the percentage of
patients with underlying disease was low (around
5.8e12.5%) in comparison with adult patients.5 Second,
multivariate analysis revealed no statistically significant
differences in the distribution of underlying illness among
three groups. Third, we obtained the same results after
exclusion of patients with underlying illness. Therefore,
the urinary antigen test is not only a diagnostic tool, but
also serves as a useful prognostic marker in clinical
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